CPTx
Richard Kiener currently serves as Unit Lead Assay Research at CPTx, having joined the company in December 2023. Prior experience includes roles as Principal Scientist and Senior Scientist at Matterhorn Biosciences from May 2022 to October 2023, and Senior Scientist and Scientist at Ridgeline Discovery between February 2021 and April 2022. Richard Kiener's career also encompasses a position as Scientist in Technology and Innovation at Medigene AG from December 2018 to December 2020 and a brief tenure as a Visiting Researcher at Fred Hutch in mid-2018. Academic credentials include a Dr. rer. nat. degree in Biology from the University of Regensburg, earned between 2014 and 2018.
This person is not in the org chart
This person is not in any teams
CPTx
At CPTx, we develop new treatment paradigms across unmet medical challenges, with an initial focus on infectious diseases. The flexibility and precision of CPTx's platform support multivalent drug development, which is crucial for addressing complex disease states involving multiple binding sites, such as viruses, cancer, and autoimmune diseases.